Last $49.55 USD
Change Today +0.30 / 0.61%
Volume 12.9M
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
London
Frankfurt
SIX Swiss Ex
As of 8:04 PM 12/21/12 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John C. Lechleiter Ph.D.

Chairman, Chief Executive Officer and President, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 44 board members in 6 different organizations across 4 different industries.

See Board Relationships
58$16,370,094
As of Fiscal Year 2011

Background*

Dr. John C. Lechleiter, Ph.D., serves as the Chairman, President and Chief Executive Officer of Eli Lilly and Company. Dr. Lechleiter serves as Treasurer at Pharmaceutical Research and Manufacturers of America. He served as President and Chief Operating Officer of Lilly, beginning in 2005, when he joined the board. In 2004, he became Lilly’s Executive Vice President for pharmaceutical operations. Prior to that, he served as Executive Vice President for pharmaceutical ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: 317-276-3492

Board Members Memberships*

Treasurer and Director
Director
Director
1999-N/A
Former Director, Member of Audit Committee and Member of Compensation and Incentive Committee
2005-Present
Chairman, Chief Executive Officer and President
2009-Present
Independent Director, Member of Compensation Committee and Member of Corporate Responsibility Committee

Education*

Doctorate
Harvard University
PhD 1980
Harvard University
Master's Degree 1980
Harvard University
BS 1975
Xavier University

Other Affiliations*

Annual Compensation*

Salary$1,500,000
Total Annual Compensation$1,500,000

Stock Options*

Restricted Stock Awards$5,625,000
All Other Compensation$90,000
Exercisable Options708,775
Total Number of Options708,775

Total Compensation*

Total Annual Cash Compensation$4,215,000
Total Short Term Compensation$1,500,000
Other Long Term Compensation$5,715,000
Total Calculated Compensation$16,370,094
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $49.55 USD +0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chief Executive Officer, President, Chief Operating Officer and Director
Amgen Inc.
$1.0M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Science & Technology Committee
Bristol-Myers Squibb Company
$1.5M
John C. Martin Ph.D.Chairman of the Board and Chief Executive Officer
Gilead Sciences Inc.
$1.4M
Pascal Soriot Chief Executive Officer and Executive Director
AstraZeneca PLC
--
Yasuchika Hasegawa Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
--
Compensation as of Fiscal Year 2011.

Post a JobJobs

View all jobs

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.